Researchers find hope in diabetes battle

Sep 16, 2006

Canadian researchers have found what they hope is a magic bullet in combating diabetes.

McMasters University scientists are crediting extra use by the commonly prescribed Rosiglitazone for the hope of cutting the diabetes epidemic in half, the Hamilton Spectator said.

Widely used to treat type 2 diabetes, Rosiglitazone has been found effective for those at highest risk because of genetics, age or obesity, making it what researchers call the first line of defense for diabetes.

The results of the $25 million study were presented Friday at the annual meeting of the European Association for the Study of Diabetes in Copenhagen.

Copyright 2006 by United Press International

Explore further: Mutant protein in muscle linked to neuromuscular disorder

add to favorites email to friend print save as pdf

Related Stories

New biomedical animations make their debut

Apr 10, 2014

Three new Australian biomedical animations will debut today, showcasing a world of pulsating cells, writhing proteins and dividing DNA as they capture Australian research and bring it to life.

Wearable electronic skin delivers drugs and stores data

Apr 08, 2014

Average life expectancy has nearly doubled since 1800, thanks to progress in medicine. Most of that was made by developing drugs and improving public health services. The medical revolution of the 21st century ...

Japan lab says stem cell research falsified (Update 3)

Apr 01, 2014

The finding that a lead researcher falsified data in a widely heralded stem-cell research paper is a setback for Japan's efforts to promote its advanced research, but also a symptom of the pressure for breakthroughs ...

Combating obesity with new Okinawan rice

Mar 27, 2014

In recent years, Okinawa has recorded the dubious distinction of having the highest obesity rate in Japan. Preventing obesity-related diseases is an urgent issue. Professor Hidetoshi Saze of the OIST Plant ...

Recommended for you

Firm targets 3D printing synthetic tissues, organs

17 minutes ago

(Medical Xpress)—A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term the company ...

Survival hope for melanoma patients thanks to new vaccine

20 minutes ago

(Medical Xpress)—University of Adelaide researchers have discovered that a new trial vaccine offers the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability ...

New clinical trial launched for advance lung cancer

3 hours ago

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

User comments : 0

More news stories

Down's chromosome cause genome-wide disruption

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

Sony's PlayStation 4 sales top seven million

Sony says it has sold seven million PlayStation 4 worldwide since its launch last year and admitted it can't make them fast enough, in a welcome change of fortune for the Japanese consumer electronics giant.